Harnessing Natural Killer Cells in Cancer Immunotherapy: A Review of Mechanisms and Novel Therapies

by Frederique St-Pierre, Shailender Bhatia, Sunandana Chandra
Published 2021-04-01

Immunotherapy for Merkel cell carcinoma: a turning point in patient care

by Isaac S. Chan, Shailender Bhatia, Howard L. Kaufman, Evan J. Lipson
Published 2018-03-01

Economics of alternative dosing strategies for pembrolizumab and nivolumab at a single academic cancer center

by Evan Hall, Jenny Zhang, Eun Jeong Kim, Grace Hwang, Gilbert Chu, Shailender Bhatia, Sunil Reddy
Published 2020-03-01

819 Concurrent treatment with GM-CSF immunoembolization of hepatic metastases and systemic immune checkpoint inhibitors to overcome immune evasion in patients with metastatic uveal...

by Evan Hall, Shailender Bhatia, Joshua Veatch, Wayne Monsky, Natalie J Miller, Jacob Leary, William McCamy
Published 2023-11-01

Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinoma

by Dirk Schadendorf, Paul Nghiem, Shailender Bhatia, Axel Hauschild, Philippe Saiag, Lisa Mahnke, Subramanian Hariharan, Howard L. Kaufman
Published 2017-10-01

628 Real-world clinical outcomes among patients with advanced Merkel cell carcinoma treated with avelumab in academic medical centers in the United States

by Shailender Bhatia, Paul Nghiem, S Phani Veeranki, Alejandro Vanegas, Kristina Lachance, Lisa Tachiki, Kevin Chiu, Emily Boller, Murtuza Bharmal
Published 2021-11-01

Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review study

by Shailender Bhatia, Paul Nghiem, Alejandro Vanegas, Kristina Lachance, Lisa Tachiki, Kevin Chiu, Emily Boller, Murtuza Bharmal, S Phani Veeranki
Published 2022-08-01

Adverse events of immune checkpoint therapy alone versus when combined with vascular endothelial growth factor inhibitors: a pooled meta-analysis of 1735 patients

by Iuliia Kovalenko, Wern Lynn Ng, Yimin Geng, Yinghong Wang, Pavlos Msaouel, Shailender Bhatia, Petros Grivas, Raed Benkhadra, Omar Alhalabi
Published 2024-01-01

610 ImmunoRad: a stratified phase II trial of image guided hypofractionated radiotherapy with concurrent nelfinavir & PD-1 inhibition in advanced melanoma, lung cancer & renal cell...

by Shailender Bhatia, Ramesh Rengan, Sylvia M Lee, Scott S Tykodi, Jing Zeng, Mary Redman, Peter H Goff, Kelsey K Baker
Published 2023-11-01

Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512.

by Shailender Bhatia, James Moon, Kim A Margolin, Jeffrey S Weber, Christopher D Lao, Megan Othus, Ana M Aparicio, Antoni Ribas, Vernon K Sondak
Published 2012-01-01

Complete resolution of PD-1 refractory, locoregionally advanced Merkel cell carcinoma with talimogene laherparepvec

by Neha Singh, BS, Erin McClure, BS, Coley Doolittle-Amieva, PA-C, Upendra Parvathaneni, MD, Shailender Bhatia, MD, Ata S. Moshiri, MD, MPH
Published 2023-06-01

Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series

by Jaclyn LoPiccolo, Megan D. Schollenberger, Sumia Dakhil, Samuel Rosner, Osama Ali, William H. Sharfman, Ann W. Silk, Shailender Bhatia, Evan J. Lipson
Published 2019-07-01

Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report

by Jacob Appelbaum, David Wells, Joseph B. Hiatt, Gideon Steinbach, F. Marc Stewart, Hannah Thomas, Paul Nghiem, Raj P. Kapur, John A. Thompson, Shailender Bhatia
Published 2018-08-01

545 A phase 2 study of retifanlimab in patients with advanced or metastatic merkel cell carcinoma (MCC) (POD1UM-201)

by Celeste Lebbe, Shailender Bhatia, Melissa Burgess, Jean-Jaques Grob, Sadhna Shankar, Giovanni Grignani, Piotr Rutkowski, Michele Guida, Chuan Tian, Natalie Prinzi, Enrica Teresa Tanda, Jennifer Pulini
Published 2021-11-01

Clitoral metastasis of vulvar melanoma treated with talimogene laherparepvec

by Erin M. McClure, BS, Neha Singh, BS, Kim G. Abson, MD, MPH, Shailender Bhatia, MD, Heidi J. Gray, MD, Laura S. Brown, PhD, ABPP, Ata S. Moshiri, MD, MPH
Published 2023-02-01

Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy

by Natalie J. Miller, Candice D. Church, Steven P. Fling, Rima Kulikauskas, Nirasha Ramchurren, Michi M. Shinohara, Harriet M. Kluger, Shailender Bhatia, Lisa Lundgren, Martin A. Cheever, Suzanne L. Topalian, Paul Nghiem
Published 2018-11-01

Management and Prognosis of Cardiac Metastatic Merkel Cell Carcinoma: A Case–Control Study and Literature Review

by Tomoko Akaike, Kelsey Cahill, Gensuke Akaike, Emily T. Huynh, Daniel S. Hippe, Michi M. Shinohara, Jay Liao, Smith Apisarnthanarax, Upendra Parvathaneni, Evan Hall, Shailender Bhatia, Richard K. Cheng, Paul Nghiem, Yolanda D. Tseng
Published 2022-11-01

661 Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function

by Evan Hall, Stanley Riddell, Sylvia Lee, David Byrd, Shailender Bhatia, Scott Tykodi, Raphael Gottardo, Naina Singhi, Ata Moshiri, Evan Newell, Carolyn Shasha, Julia Szeto, Teresa Kim, Venu Pillarisetty, Kimberly Smythe, Joshua Veatch
Published 2021-11-01

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial

by Howard L. Kaufman, Jeffery S. Russell, Omid Hamid, Shailender Bhatia, Patrick Terheyden, Sandra P. D’Angelo, Kent C. Shih, Céleste Lebbé, Michele Milella, Isaac Brownell, Karl D. Lewis, Jochen H. Lorch, Anja von Heydebreck, Meliessa Hennessy, Paul Nghiem
Published 2018-01-01

Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillance

by Christopher W. Lewis, Jamiluddin Qazi, Daniel S. Hippe, Kristina Lachance, Hannah Thomas, Maclean M. Cook, Ilsa Juhlin, Neha Singh, Zoe Thuesmunn, Seesha R. Takagishi, Aubriana McEvoy, Coley Doolittle‐Amieva, Shailender Bhatia, Kelly G. Paulson, Ryan B. O'Malley, Carolyn L. Wang, Paul Nghiem
Published 2020-02-01